Finding 980271 (2022-007)

Significant Deficiency Repeat Finding
Requirement
N
Questioned Costs
-
Year
2022
Accepted
2024-06-28

AI Summary

  • Core Issue: The Organization lacks written policies required by Uniform Guidance for key areas like internal controls and financial management.
  • Impacted Requirements: Non-compliance with 2 CFR regulations could lead to improper expense management and potential funding issues.
  • Recommended Follow-Up: Update the fiscal manual to include necessary policies to ensure compliance with Uniform Guidance.

Finding Text

#2022-007 – Significant Deficiency – Special Tests Criteria Uniform Guidance (UG) requires non-Federal entities that receive grant funding to have written policies in the following areas: Internal Controls (2 CFR 200.303) Travel (2 CFR 200.474) Financial Management and Accounting which includes Cash Management and Allowability (2CFR 200.302) Personnel Compensation – Time and Effort Reporting (2CFR 200.430(i)) Conflict of Interest/Disclosures (2CFR 200.318) Procurement (2CFR 200.319) Condition During the audit we noted that the Organization does not have written policies in place over these areas in accordance with UG. Cause The Organization was not aware of the requirement to have these written policies in place. Effect The potential effect of not having these policies in place is that the Organization’s expenses are not in accordance with UG. Questioned Costs None Perspective Information No policies or procedures were noted that are in accordance with UG. As a response to the prior year finding, the Organization noted that they will add policies to the fiscal manual for future compliance. Identification as a repeat finding A similar issue was noted in prior year finding #2021-007. Recommendation We recommend that the Organization update the fiscal manual to include policies that are compliant with UG.

Categories

Procurement, Suspension & Debarment Allowable Costs / Cost Principles Cash Management Reporting Significant Deficiency

Other Findings in this Audit

  • 403816 2022-001
    Material Weakness Repeat
  • 403817 2022-002
    Material Weakness Repeat
  • 403818 2022-003
    Material Weakness Repeat
  • 403819 2022-004
    Material Weakness Repeat
  • 403820 2022-005
    Material Weakness Repeat
  • 403821 2022-006
    Material Weakness Repeat
  • 403822 2022-007
    Significant Deficiency Repeat
  • 403823 2022-001
    Material Weakness Repeat
  • 403824 2022-002
    Material Weakness Repeat
  • 403825 2022-003
    Material Weakness Repeat
  • 403826 2022-004
    Material Weakness Repeat
  • 403827 2022-005
    Material Weakness Repeat
  • 403828 2022-006
    Material Weakness Repeat
  • 403829 2022-007
    Significant Deficiency Repeat
  • 980258 2022-001
    Material Weakness Repeat
  • 980259 2022-002
    Material Weakness Repeat
  • 980260 2022-003
    Material Weakness Repeat
  • 980261 2022-004
    Material Weakness Repeat
  • 980262 2022-005
    Material Weakness Repeat
  • 980263 2022-006
    Material Weakness Repeat
  • 980264 2022-007
    Significant Deficiency Repeat
  • 980265 2022-001
    Material Weakness Repeat
  • 980266 2022-002
    Material Weakness Repeat
  • 980267 2022-003
    Material Weakness Repeat
  • 980268 2022-004
    Material Weakness Repeat
  • 980269 2022-005
    Material Weakness Repeat
  • 980270 2022-006
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.788 Opioid Str $1.16M
93.959 Block Grants for Prevention and Treatment of Substance Abuse $615,643